Treatment of Acute Promyelocytic Leukemia with High White Cell Blood Counts.

por Kelaidi, C., Adès, L., Fenaux, P.
Publicado 2011

Does increasing the JAK2V617F assay sensitivity allow to identify more patients with MPN?

por Kouroupi, E, Kiladjian, J-J, Dosquet, C, Menot, M-L, Bonnin, N, Ades, L, Vainchenker, W, Chomienne, C, Cassinat, B
Publicado 2012

PB1805: INSIGHTS FROM ORAL AZACITIDINE EARLY ACCESS PROGRAM IN FRANCE: PATIENT POPULATION WITH ACUTE MYELOID LEUKEMIA RECEIVING ORAL-AZA FOR MAINTENANCE OF COMPLETE REMISSION AFTER...

por Raffoux, E., De Botton, S., Ades, L., Carré, M., Cluzeau, T., Saillard, C., Heiblig, M., Beckerich, F., Gastaud, L., Dupuis, A., Richez, U., Dumas, P.-Y.
Publicado 2022

pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukem...

por Patel, S, Guerenne, L, Gorombei, P, Omidvar, N, Schlageter, M-H, Alex, A A, Ganesan, S, West, R, Adès, L, Mathews, V, Krief, P, Pla, M, Fenaux, P, Chomienne, C, Padua, R A
Publicado 2015

Preclinical modeling of myelodysplastic syndromes

por Rouault-Pierre, K, Mian, S A, Goulard, M, Abarrategi, A, Di Tulio, A, Smith, A E, Mohamedali, A, Best, S, Nloga, A-M, Kulasekararaj, A G, Ades, L, Chomienne, C, Fenaux, P, Dosquet, C, Mufti, G J, Bonnet, D
Publicado 2017

Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

por Kubasch, A. S., Peterlin, P., Cluzeau, T., Götze, K. S., Sockel, K., Teipel, R., Jentzsch, M., Attalah, H., Sebert, M., Chermat, F., Gloaguen, S., Puttrich, M., Cross, M., Schneider, M., Kayser, S., Schipp, D., Giagounidis, A., Tirado-Gonzalez, I., Descot, A., van de Loosdrecht, A., Weigert, A., Metzeler, K. H., Fenaux, P., Medyouf, H., Platzbecker, U., Ades, L.
Publicado 2023